Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Lee

Showing results (221-230 of 230) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 230 results.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2022
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancerDavid J Pinato, Daniela Ferrante, Juan Aguilar-Company, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2023
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast CancerMarco Tagliamento, Alessandra Gennari, Matteo Lambertini, et al.
JAMA Oncology|December 22, 2022
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional EvaluationLennard Y W Lee, Michael Tilby, Thomas Starkey, et al.
Journal for Immunotherapy of Cancer|March 23, 2021
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory ScoreGino M Dettorre, Saoirse Dolly, Angela Loizidou, et al.
Scientific Reports|July 25, 2023
A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)Thomas Starkey, Maria C Ionescu, Michael Tilby, et al.
Cancer Discovery|August 2, 2020
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patientsDavid J Pinato, Alberto Zambelli, Juan Aguilar-Company, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2021
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European studyDavid J Pinato, Lorenza Scotti, Alessandra Gennari, et al.
The Lancet. Oncology|March 10, 2023
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registryAlessio Cortellini, Josep Tabernero, Uma Mukherjee, et al.
Journal of the National Cancer Institute|April 13, 2022
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid RegistryAlessio Cortellini, Alessandra Gennari, Fanny Pommeret, et al.
Autophagy|September 12, 2012
Guidelines for the use and interpretation of assays for monitoring autophagyDaniel J Klionsky, Fabio C Abdalla, Hagai Abeliovich, et al.
Pageof 23

Showing results (221-230 of 230) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 230 results.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2022
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancerDavid J Pinato, Daniela Ferrante, Juan Aguilar-Company, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2023
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast CancerMarco Tagliamento, Alessandra Gennari, Matteo Lambertini, et al.
JAMA Oncology|December 22, 2022
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional EvaluationLennard Y W Lee, Michael Tilby, Thomas Starkey, et al.
Journal for Immunotherapy of Cancer|March 23, 2021
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory ScoreGino M Dettorre, Saoirse Dolly, Angela Loizidou, et al.
Scientific Reports|July 25, 2023
A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)Thomas Starkey, Maria C Ionescu, Michael Tilby, et al.
Cancer Discovery|August 2, 2020
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patientsDavid J Pinato, Alberto Zambelli, Juan Aguilar-Company, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2021
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European studyDavid J Pinato, Lorenza Scotti, Alessandra Gennari, et al.
The Lancet. Oncology|March 10, 2023
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registryAlessio Cortellini, Josep Tabernero, Uma Mukherjee, et al.
Journal of the National Cancer Institute|April 13, 2022
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid RegistryAlessio Cortellini, Alessandra Gennari, Fanny Pommeret, et al.
Autophagy|September 12, 2012
Guidelines for the use and interpretation of assays for monitoring autophagyDaniel J Klionsky, Fabio C Abdalla, Hagai Abeliovich, et al.
Pageof 23